Deciding
What a consultation should cover, what good consent looks like, the questions worth asking, how to think about cost, and the option of declining.
The final chapter is about the decision rather than the treatment. It covers consultation and consent, the questions a clinic cannot answer with marketing copy, how the category compares with its neighbours, cost, and deciding not to.
- 6.1What a consultation should cover
A consultation is the treatment's most important component and the one most often compressed into a sales conversation with a form at the end.
- 6.2What good consent looks like
A signed form is evidence that something happened. It is not evidence that the something was consent.
- 6.3Questions marketing copy cannot answer
The consolidated list. Every question here has a short factual answer, and the pattern of responses tells you more than any individual one.
- 6.4Comparing the regenerative injectables
These treatments share a marketing category and very little else. Comparing them by what they are, rather than by what they promise, is more useful than any ranking.
- 6.5Cost, without a price list
The question people most want answered is what it costs. The answer that helps is not a number.
- 6.6Deciding not to
Every article in this document has been written on the assumption that not having the treatment is a real option. This one says so directly.
Revisions to this document
This reference is revised when the evidence changes. Subscribe and you will be told what was revised, what the verdict was before, and what it is now.
One email when this document is revised, with what changed and why. Any sponsor line is labelled as such and can never influence an evidence verdict. Rates are published on the newsletter page. We do not sell, share or rent the list. Unsubscribe from any email.